▲ 7 r/Inovio
May 20, 2026 VGX-3100 China Phase III Bedside Trial HPV-303CHN Achieves Positive Topline Results 🧬🧬🧬🌍🌎🌏
u/WallStBull10Point0 — 2 days ago
u/WallStBull10Point0
▲ 7 r/Inovio
May 20, 2026 Positive topline results from the Phase III clinical trial of VGX-3100 in China (HPV-303CHN).
in the primary analysis set, the response rate of the VGX-3100 group was statistically significantly better than that of the placebo group, meeting the statistical superiority criteria. The supporting analysis set was consistent with the primary analysis set overall, and the results were robust and reliable. Furthermore, an enhanced HPV-specific immune response was detected in the VGX-3100 administration group. The HPV-303CHN Phase III pivotal clinical trial in China has successfully met its pre-defined primary efficacy endpoint.https://mp.weixin.qq.com/s/55plYeKHYUHz2zrPMk2tSw
u/WallStBull10Point0 — 2 days ago